Suppr超能文献

内生细菌芽孢杆菌 15F 所产生的表面活性剂对表皮葡萄球菌生物膜的控制

Control of Staphylococcus epidermidis biofilm by surfactins of an endophytic bacterium Bacillus sp. 15 F.

机构信息

Laboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, University of Sfax, P O Box 1177, Sidi Mansour Road, Sfax 3018, Tunisia.

Sorbonne Université, CNRS, Laboratoire de Biodiversité et Biotechnologies Microbiennes (LBBM), Banyuls-sur-Mer 66650, France.

出版信息

Enzyme Microb Technol. 2024 Oct;180:110477. doi: 10.1016/j.enzmictec.2024.110477. Epub 2024 Jul 3.

Abstract

The present paper deals with the preparation and annotation of a surfactin(s) derived from a culture of the endophytic bacterium Bacillus 15 F. The LC-MS analysis of the acetonitrile fraction confirmed the presence of surfactins Leu/Ile7 C15, Leu/Ile7 C14 and Leu/Ile7 C13 with [M+H] at m/z 1036.6895, 1022.6741 and 1008.6581, respectively. Various concentrations of the surfactin(s) (hereafter referred to as surfactin-15 F) were used to reduce the adhesion of Staphylococcus epidermidis S61, which served as a model for studying antibiofilm activity on polystyrene surfaces. Incubation of Staphylococcus epidermidis S61 with 62.5 µg/ml of surfactin-15 F resulted in almost complete inhibition of biofilm formation (90.3 ± 3.33 %), and a significant reduction of cell viability (resazurin-based fluorescence was more than 200 times lower). The antiadhesive effect of surfactin-15 F was confirmed by scanning electron microscopy. Surfactin-15 F demonstrated an eradication effect against preformed biofilm, causing severe disruption of Staphylococcus epidermidis S61 biofilm structure and reducing viability. The results suggest that surfactins produced by endophytic bacteria could be an alternative to synthetic products. Surfactin-15 F, used in wound dressings, demonstrated an efficient treatment of the preformed Staphylococcus epidermidis S61 biofilm, and thus having a great potential in medical applications.

摘要

本文涉及从内生细菌芽孢杆菌 15 F 的培养物中制备和注释表面活性剂(s)。LC-MS 分析乙腈馏分证实存在亮氨酸/异亮氨酸 7 C15、亮氨酸/异亮氨酸 7 C14 和亮氨酸/异亮氨酸 7 C13 表面活性剂,其 [M+H]+ 分别为 m/z 1036.6895、1022.6741 和 1008.6581。使用不同浓度的表面活性剂(s)(以下简称表面活性剂 15 F)来减少表皮葡萄球菌 S61 的黏附,表皮葡萄球菌 S61 作为研究聚苯乙烯表面抗生物膜活性的模型。用 62.5µg/ml 的表面活性剂 15 F 孵育表皮葡萄球菌 S61 几乎完全抑制生物膜形成(90.3±3.33%),细胞活力显著降低(基于 Resazurin 的荧光降低了 200 多倍)。表面活性剂 15 F 的抗黏附作用通过扫描电子显微镜得到证实。表面活性剂 15 F 对已形成的生物膜具有消除作用,导致表皮葡萄球菌 S61 生物膜结构严重破坏,活力降低。结果表明,内生细菌产生的表面活性剂可以替代合成产品。表面活性剂 15 F 用于伤口敷料,对已形成的表皮葡萄球菌 S61 生物膜显示出有效的治疗作用,因此在医学应用中有很大的潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验